Healthcare
Silverfleet offloads Aesica for £230m
Silverfleet acquired Aesica in 2011 from previous backers LDC
VC-backed Probiodrug to list on Euronext
Consortium-backed biopharmaceutical company seeks funds for drug development
Adaptimmune raises $104m series-A
Company develops treatments for cancer and infectious diseases
HTGF, Bayern Kapital back medineering
VC firm Born2Grow committed €500,000 of the total
Cambridge Innovation leads £4m round for Inviata
Deal is first for Cambridge Innovation in life sciences sector
Molecular Partners launches Swiss IPO
Venture-capital backed biotech plans to raise CHF 125m for R&D
LBO Partners' AMS bolts on Asdia
Capzanine arranged a unitranche facility for the bolt-on
HC Royalty injects €45m into Cardiorentis
Swiss company focuses on treatments for acute heart failure
VC-backed Affimed raises $56m in IPO
Backers include Aeris, BioMedInvest and Life Sciences Partners
Aglaia launches Oncology Fund II
Fund focuses exclusively on biotechs developing anti-cancer therapies
VC-backed ProQR raises $97.5m in IPO
Listed Dutch biotech develops drugs designed for the treatment of genetic disorders
Permira-backed Mesa acquires MVS
Mesa and UK-based Asteral merged in August with Permira's support
NCI becomes majority shareholder of Didactic
UI Gestion and BPI France exit the business
Gilde Healthcare leads €12.2m AM-Pharma round
Deal marks company's fifth funding round
CCMP Capital closes $3.6bn fund
Fund will invest $100-500m in US and European LBOs
Spring Ventures backs Creative Care MBO
Mike Quinn of Baker Tilly brokered the deal
SHS invests in TRI Dental Implants
GP invests via SHS-IV vehicle, due to close this year
BPI France invests €10m in Poxel series-B extension
Company is backed by several VCs including EdRrip
BayBG invests in AMW
Pharmaceutical company secures €5m for developing new drug delivery technologies
Inventure leads €2m Blueprint Genetics funding round
Finnish VC joins business angels and Tekes as investors
HTGF invests in i3 Membrane
Company plans to launch its steel membranes in June 2015
EdRip et al. sell Sapiens in trade sale
Medtronics buys business in an all-cash transaction
Gimv et al. exit Covagen in trade sale
Covagen raised CHF 58.9m prior to sale
VC-backed MedaPhor to float
Planned offering will give company ТЃ10.1m market cap